Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.8M Sell
100,000
-20,900
-17% -$2.41M 0.67% 59
2026
Q1
$14.4M Hold
120,900
0.96% 40
2025
Q4
$16.5M Hold
120,900
1.06% 36
2025
Q3
$17.8M Hold
120,900
1% 42
2025
Q2
$15.6M Hold
120,900
0.9% 37
2025
Q1
$14.4M Hold
120,900
1.18% 33
2024
Q4
$14M Hold
120,900
0.78% 44
2024
Q3
$16.3M Hold
120,900
0.85% 43
2024
Q2
$16.4M Hold
120,900
0.86% 42
2024
Q1
$15.6M Buy
120,900
+27,000
+29% +$3.26M 0.75% 37
2023
Q4
$10.7M Hold
93,900
0.59% 60
2023
Q3
$8.55M Hold
93,900
0.51% 66
2023
Q2
$10.6M Sell
93,900
-87,100
-48% -$9.21M 0.57% 56
2023
Q1
$19M Buy
181,000
+91,000
+101% +$9.5M 1.05% 37
2022
Q4
$9.95M Hold
90,000
0.6% 57
2022
Q3
$7.86M Hold
90,000
0.53% 75
2022
Q2
$7.04M Hold
90,000
0.53% 78
2022
Q1
$7.67M Hold
90,000
0.37% 96
2021
Q4
$10.8M Buy
90,000
+40,000
+80% +$4.96M 0.47% 73
2021
Q3
$6.18M Buy
+50,000
New +$6.43M 0.32% 94

Other funds holding XYL

Rheos Capital Works's XYL Position: Q2 2026 in Review

Rheos Capital Works reduced its Xylem (XYL) stake by 17% in Q2 2026, selling an estimated $2.41M and leaving 100,000 shares worth $11.8M. The position accounts for 0.67% of the portfolio, ranked #59.

Rheos Capital Works first reported a position in XYL in Q3 2021 and has held it in 20 quarters since. The position peaked at $19M in Q1 2023. 652 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Rheos Capital Works held 100,000 shares of Xylem worth $11.8M as of Q2 2026.
  • Rheos Capital Works sold 20,900 Xylem shares in Q2 2026, an estimated $2.41M.
  • Xylem made up 0.67% of Rheos Capital Works's portfolio in Q2 2026, its #59 holding.
  • Rheos Capital Works first reported a position in Xylem in Q3 2021 and has held it in 20 quarters since.
  • Rheos Capital Works's Xylem position peaked at $19M in Q1 2023.
  • 652 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Rheos Capital Works's 13F filing for Q2 2026, filed 7 Aug 2026.